Global Non-Hematological Cancers Market to 2021 - Strong Growth Driven by Increased Uptake of Low Toxicity Targeted Treatments and Versatile Biologics
In 2012, there were 32.6 million people living with any type of cancer within five years of diagnosis, non-hematological cancers are thought to account for 94% of global cancer prevalence. The key cancer indications of this report, namely breast, colorectal, lung and prostate cancer, constitute approximately 51% of global cancer prevalence.
View full press release